Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
<Group xmlns="http://hl7.org/fhir">
<id value="172480"/>
<meta>
<versionId value="7"/>
<lastUpdated value="2023-12-04T16:22:54.673Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/outcome-definition"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Group</b><a name="172480"> </a><a name="hc172480"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceGroup "172480" Version "7" Updated "2023-12-04 16:22:54+0000" </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-outcome-definition.html">OutcomeDefinition</a></p></div><p><b>Artifact related artifact</b>: </p><p><b>Artifact Title</b>: OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control</p><p><b>Artifact URL</b>: <a href="https://fevir.net/resources/Group/172480">https://fevir.net/resources/Group/172480</a></p><p><b>Artifact Publisher</b>: Computable Publishing LLC</p><p><b>Artifact Copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>Artifact Contact</b>: <a href="mailto:support@computablepublishing.com">support@computablepublishing.com</a></p><p><b>Artifact Author</b>: Brian S. Alper: </p><p><b>CombinationMethod</b>: all-of</p><blockquote><p><b>modifierExtension[http://hl7.org/fhir/StructureDefinition/artifact-status]</b></p></blockquote><p><b>identifier</b>: FEvIR Object Identifier/172480</p><p><b>type</b>: animal</p><p><b>membership</b>: definitional</p><p><b>name</b>: OutcomeDefinition_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control</p><p><b>description</b>: The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years</p><blockquote><p><b>characteristic</b></p><p><b>CharacteristicDescription</b>: hemoglobin A1c less than 7.0%</p><blockquote><p><b>CharacteristicTiming</b></p><blockquote><p><b>url</b></p><code>contextCode</code></blockquote><p><b>value</b>: Enrollment in clinical trial <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOWMED CT</a>#709491003)</span></p><blockquote><p><b>url</b></p><code>offset</code></blockquote><p><b>value</b>: 5 years<span style="background: LightGoldenRodYellow"> (Details: UCUM code a = 'a')</span></p><blockquote><p><b>url</b></p><code>text</code></blockquote><p><b>value</b>: at 5 years</p></blockquote><p><b>code</b>: Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a>#59261-8)</span></p><p><b>value</b>: <7 %<span style="background: LightGoldenRodYellow"> (Details: UCUM code % = '%')</span></p><p><b>exclude</b>: false</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>CharacteristicDescription</b>: low-density lipoprotein cholesterol less than 100 mg/dL</p><blockquote><p><b>CharacteristicTiming</b></p><blockquote><p><b>url</b></p><code>contextCode</code></blockquote><p><b>value</b>: Enrollment in clinical trial <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOWMED CT</a>#709491003)</span></p><blockquote><p><b>url</b></p><code>offset</code></blockquote><p><b>value</b>: 5 years<span style="background: LightGoldenRodYellow"> (Details: UCUM code a = 'a')</span></p><blockquote><p><b>url</b></p><code>text</code></blockquote><p><b>value</b>: at 5 years</p></blockquote><p><b>code</b>: Cholesterol in LDL [Mass/volume] in Serum or Plasma <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a>#2089-1)</span></p><p><b>value</b>: <100 mg/dL<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg/dL = 'mg/dL')</span></p><p><b>exclude</b>: false</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>CharacteristicDescription</b>: systolic blood pressure less than 130 mm Hg</p><blockquote><p><b>CharacteristicTiming</b></p><blockquote><p><b>url</b></p><code>contextCode</code></blockquote><p><b>value</b>: Enrollment in clinical trial <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOWMED CT</a>#709491003)</span></p><blockquote><p><b>url</b></p><code>offset</code></blockquote><p><b>value</b>: 5 years<span style="background: LightGoldenRodYellow"> (Details: UCUM code a = 'a')</span></p><blockquote><p><b>url</b></p><code>text</code></blockquote><p><b>value</b>: at 5 years</p></blockquote><p><b>code</b>: Systolic blood pressure <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a>#8480-6)</span></p><p><b>value</b>: <130 mm Hg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mm[Hg] = 'mm[Hg]')</span></p><p><b>exclude</b>: false</p></blockquote></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact">
<valueRelatedArtifact>
<type value="cite-as"/>
<citation
value="OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 172480. Revised 2023-11-02. Available at: https://fevir.net/resources/Group/172480. Computable resource at: https://fevir.net/resources/Group/172480."/>
</valueRelatedArtifact>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-title">
<valueString
value="OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control"/>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-url">
<valueUri value="https://fevir.net/resources/Group/172480"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-publisher">
<valueString value="Computable Publishing LLC"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-copyright">
<valueMarkdown
value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-contact">
<valueContactDetail>
<telecom>
<system value="email"/>
<value value="support@computablepublishing.com"/>
</telecom>
</valueContactDetail>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
<valueContactDetail>
<name value="Brian S. Alper"/>
</valueContactDetail>
</extension>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/combination-method">
<valueCode value="all-of"/>
</extension>
<modifierExtension
url="http://hl7.org/fhir/StructureDefinition/artifact-status">
<valueCode value="active"/>
</modifierExtension>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="172480"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<type value="animal"/>
<membership value="definitional"/>
<name
value="OutcomeDefinition_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control"/>
<description
value="The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years"/>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description">
<valueMarkdown value="hemoglobin A1c less than 7.0%"/>
</extension>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-timing">
<extension url="contextCode">
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="709491003"/>
<display value="Enrollment in clinical trial"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="offset">
<valueDuration>
<value value="5"/>
<unit value="years"/>
<system value="http://unitsofmeasure.org"/>
<code value="a"/>
</valueDuration>
</extension>
<extension url="text">
<valueString value="at 5 years"/>
</extension>
</extension>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="59261-8"/>
<display
value="Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol"/>
</coding>
</code>
<valueQuantity>
<value value="7"/>
<comparator value="<"/>
<unit value="%"/>
<system value="http://unitsofmeasure.org"/>
<code value="%"/>
</valueQuantity>
<exclude value="false"/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description">
<valueMarkdown
value="low-density lipoprotein cholesterol less than 100 mg/dL"/>
</extension>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-timing">
<extension url="contextCode">
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="709491003"/>
<display value="Enrollment in clinical trial"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="offset">
<valueDuration>
<value value="5"/>
<unit value="years"/>
<system value="http://unitsofmeasure.org"/>
<code value="a"/>
</valueDuration>
</extension>
<extension url="text">
<valueString value="at 5 years"/>
</extension>
</extension>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="2089-1"/>
<display value="Cholesterol in LDL [Mass/volume] in Serum or Plasma"/>
</coding>
</code>
<valueQuantity>
<value value="100"/>
<comparator value="<"/>
<unit value="mg/dL"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg/dL"/>
</valueQuantity>
<exclude value="false"/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description">
<valueMarkdown value="systolic blood pressure less than 130 mm Hg"/>
</extension>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-timing">
<extension url="contextCode">
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="709491003"/>
<display value="Enrollment in clinical trial"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="offset">
<valueDuration>
<value value="5"/>
<unit value="years"/>
<system value="http://unitsofmeasure.org"/>
<code value="a"/>
</valueDuration>
</extension>
<extension url="text">
<valueString value="at 5 years"/>
</extension>
</extension>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="8480-6"/>
<display value="Systolic blood pressure"/>
</coding>
</code>
<valueQuantity>
<value value="130"/>
<comparator value="<"/>
<unit value="mm Hg"/>
<system value="http://unitsofmeasure.org"/>
<code value="mm[Hg]"/>
</valueQuantity>
<exclude value="false"/>
</characteristic>
</Group>
IG © 2022+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot based on FHIR 5.0.0. Generated 2024-05-16
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change